Clinical Trial Update: A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A pediatric/young adult study evaluating glofitamab as monotherapy and in combination with chemoimmunotherapy for relapsed/refractory mature B-cell non-Hodgkin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mature B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Mature B-Cell Non-Hodgkin Lymphoma | Phase 1, Phase 2 | Status: RECRUITING